Another SCFA, Sodium butyrate (SB), a renowned HDAC inhibitor [43, 44] which has gained much attention for its debated role as an immune modulator [38, 45–47], it is currently studied predominantly in IBS pathophysiology [40]. This evidence concerns the gene HDAC9 and irritable bowel syndrome.